Effects of SGLT2 inhibitors on cause-specific cardiovascular death in patients with chronic kidney disease: a meta-analysis of CKD progression trials.
Robert A FletcherWilliam G HerringtonRajiv AgarwalKaitlin J MayneClare ArnottMeg J JardineKenneth W MahaffeyVlado PerkovicNatalie StaplinDavid Collins WheelerGlenn M ChertowHiddo J Lambers HeerspinkBrendon L NeuenPublished in: Clinical journal of the American Society of Nephrology : CJASN (2024)
Keyphrases